Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01060540 · ClinicalTrials.gov registry record · NA
Genetic Testing for Type 2 Diabetes
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 601
- Enrollment target
NCT01060540 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 601 participants.
The verdict
NCT01060540, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 601 participants
- Enrollment target
Study Summary
In this 6-month randomized, controlled trial, we examined whether providing participants with genetic test results and counseling regarding their risk for type 2 diabetes would motivate them to improve their health behaviors and lose weight to reduce their diabetes risk. We hypothesized that participants who received conventional diabetes counseling plus genetic test results and counseling would have at least 6 lb greater weight loss at 3 months than participants who received conventional diabetes counseling without genetic test results.
Interventions
- GENETIC genetic testing for type 2 diabetes
- BEHAVIORAL Conventional risk counseling
- BEHAVIORAL eye disease counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 601 participants |
| Start Date | 2010-08 |
| Est. Completion | 2013-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01060540
The ClinicalTrials.gov registry entry for NCT01060540 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 601 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which genetic testing for type 2 diabetes is the first listed.
NCT01060540 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01060540 about?
NCT01060540 is a clinical study titled "Genetic Testing for Type 2 Diabetes". In this 6-month randomized, controlled trial, we examined whether providing participants with genetic test results and counseling regarding their risk for type 2 diabetes would motivate them to improve their health behaviors and lose weight to reduce their diabetes risk. We hypothesized that partici...
What is the current status of trial NCT01060540?
This trial is currently completed. It is a NA study. The enrollment target is 601 participants. The study started on 2010-08. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01060540?
The interventions under investigation include: genetic testing for type 2 diabetes (GENETIC), Conventional risk counseling (BEHAVIORAL), eye disease counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT01060540?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.